These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 15723830)
1. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function. Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830 [TBL] [Abstract][Full Text] [Related]
2. Kinase activity-independent suppression of p73alpha by AMP-activated kinase alpha (AMPKalpha). Lee YG; Lee SW; Sin HS; Kim EJ; Um SJ Oncogene; 2009 Feb; 28(7):1040-52. PubMed ID: 19079340 [TBL] [Abstract][Full Text] [Related]
3. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y. Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641 [TBL] [Abstract][Full Text] [Related]
4. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232 [TBL] [Abstract][Full Text] [Related]
5. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. Kim EJ; Park JS; Um SJ Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772 [TBL] [Abstract][Full Text] [Related]
6. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986 [TBL] [Abstract][Full Text] [Related]
7. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Di Como CJ; Gaiddon C; Prives C Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077 [TBL] [Abstract][Full Text] [Related]
8. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells. Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation. Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the p53 homolog p73 by adenoviral oncogene E1A. Das S; El-Deiry WS; Somasundaram K J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967 [TBL] [Abstract][Full Text] [Related]
11. Relief of p53-mediated telomerase suppression by p73. Toh WH; Kyo S; Sabapathy K J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740 [TBL] [Abstract][Full Text] [Related]
12. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493 [TBL] [Abstract][Full Text] [Related]
13. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. Minty A; Dumont X; Kaghad M; Caput D J Biol Chem; 2000 Nov; 275(46):36316-23. PubMed ID: 10961991 [TBL] [Abstract][Full Text] [Related]
14. Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells. Kramer S; Ozaki T; Miyazaki K; Kato C; Hanamoto T; Nakagawara A Oncogene; 2005 Jan; 24(5):938-44. PubMed ID: 15558019 [TBL] [Abstract][Full Text] [Related]
15. PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73. Munarriz E; Barcaroli D; Stephanou A; Townsend PA; Maisse C; Terrinoni A; Neale MH; Martin SJ; Latchman DS; Knight RA; Melino G; De Laurenzi V Mol Cell Biol; 2004 Dec; 24(24):10593-610. PubMed ID: 15572666 [TBL] [Abstract][Full Text] [Related]
16. UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination. Hosoda M; Ozaki T; Miyazaki K; Hayashi S; Furuya K; Watanabe K; Nakagawa T; Hanamoto T; Todo S; Nakagawara A Oncogene; 2005 Nov; 24(48):7156-69. PubMed ID: 16170377 [TBL] [Abstract][Full Text] [Related]
17. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor. Uramoto H; Wetterskog D; Hackzell A; Matsumoto Y; Funa K J Cell Sci; 2004 Oct; 117(Pt 22):5323-31. PubMed ID: 15454570 [TBL] [Abstract][Full Text] [Related]
18. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest. Vossio S; Palescandolo E; Pediconi N; Moretti F; Balsano C; Levrero M; Costanzo A Oncogene; 2002 May; 21(23):3796-803. PubMed ID: 12032848 [TBL] [Abstract][Full Text] [Related]
19. c-Jun regulates the stability and activity of the p53 homologue, p73. Toh WH; Siddique MM; Boominathan L; Lin KW; Sabapathy K J Biol Chem; 2004 Oct; 279(43):44713-22. PubMed ID: 15302867 [TBL] [Abstract][Full Text] [Related]